The Effects of Slow-Release Dexamethasone in the Treatment of Diabetic Macular Edema
<b>Objectives:</b> to evaluate the efficacy of 0.7 mg dexamethasone intravitreal implant in the treatment of patients with diabetic macular edema through mean retinal sensitivity (MRS), best corrected visual acuity (BCVA), central retinal thickness (CRT) and fixation stability. <b>...
Saved in:
| Main Authors: | Enzo Maria Vingolo, Simona Mascolo, Lorenzo Casillo, Mattia Calabro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/2/174 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal Dexamethasone Implant in the Treatment of Refractory Uveitic Macular Edema: A Case Report
by: Anisha Seth, et al.
Published: (2016-04-01) -
Dexamethasone intravitreal implant monotherapy in naive patients with macular edema secondary to retinal vein occlusion: long term follow-up retrospective cohort study
by: Gamze Karataş, et al.
Published: (2025-05-01) -
Diabetic Macular Edema in Maintenance Intravitreal Scheduling
by: Enzo Maria Vingolo, et al.
Published: (2025-05-01) -
Efficacy of Intravitreal Dexamethasone Implant (Ozurdex<sup>®</sup>) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema
by: Panagiotis Stavrakas, et al.
Published: (2025-03-01) -
Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis
by: Khaled Moghib, et al.
Published: (2025-04-01)